Publications
5600 Results
- Journal / Conference
- Journal of Clinical Oncology Apr 10;36(11):1112-1120; Feb 28 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29489429
- PMC
- PMC5891130
- Study Number(s)
- C89803
Nut consumption and survival in patients with stage III colon cancer: results from CALGB 89803 (Alliance)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 6569); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery
Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 6540); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery
Patient Comorbid Conditions and Cancer Clinical Trial Participation
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 3570); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Causal modeling of CALGB 80405 identifies network drivers of metastatic colorectal cancer (CRC)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS9599); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
- Year
- 2018
- Research Committee(s)
- Melanoma
- Study Number(s)
- CTSU/A091605
A Randomized Phase II Study of Anti-Pd1 Antibody [Mk-3475 (Pembrolizumab)] Alone Versus Anti-Pd1 Antibody plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr e16107);ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), publication only
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80802
Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB80802 (Alliance) (C8)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS4597); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8143
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 4004; ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), oral
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/E2211
A Randomized Study of Temozolomide or Temozolomide and Capecitabine in with Advanced Pancreatic Neuroendocrine Tumors: A Trial of the ECOG-ACRIN Cancer Research Group (E2211)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 5046); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL)
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E3805
Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 3504); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), oral
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/E7208